Terms: = Germ cell tumor AND PHOX2B, 8929 AND Clinical Outcome
4 results:
1. The expression of phox2b in bone marrow and peripheral blood predicts adverse clinical outcome in non-high-risk neuroblastoma.
Fan H; Xing T; Hong H; Duan C; Zhao W; Zhao Q; Wang X; Huang C; Zhu S; Jin M; Su Y; Gao C; Ma X
Pediatr Hematol Oncol; 2022 May; 39(4):343-356. PubMed ID: 34752187
[TBL] [Abstract] [Full Text] [Related]
2. phox2b Is Associated with Neuroblastoma cell Differentiation.
Yang L; Ke XX; Xuan F; Tan J; Hou J; Wang M; Cui H; Zhang Y
Cancer Biother Radiopharm; 2016 Mar; 31(2):44-51. PubMed ID: 26910576
[TBL] [Abstract] [Full Text] [Related]
3. Neonatal neuroblastoma.
Fisher JPH; Tweddle DA
Semin Fetal Neonatal Med; 2012 Aug; 17(4):207-215. PubMed ID: 22673527
[TBL] [Abstract] [Full Text] [Related]
4. MYCN promotes the expansion of phox2b-positive neuronal progenitors to drive neuroblastoma development.
Alam G; Cui H; Shi H; Yang L; Ding J; Mao L; Maltese WA; Ding HF
Am J Pathol; 2009 Aug; 175(2):856-66. PubMed ID: 19608868
[TBL] [Abstract] [Full Text] [Related]
